January 14, 2021

Fathom’s Recovery Watch Chart – Vaccine rollout: how long will it take to protect the most vulnerable?

by Fathom Consulting.

The UK government has targeted 14 million vaccinations by mid-February, with the aim of providing initial doses to key workers, the clinically extremely vulnerable and the over-70s. To date, just over 2.8 million doses have been administered, approximately 20% of what would be required under a one-dose strategy (or 10% on the double-dose approach). If doses continue at the current rate of 1.4 million per week, that goal could be achieved by the middle of March, a month later than targeted. Of course, the rate ought to pick up as mass vaccination sites come on stream, and so mid-March may well be a pessimistic prediction. Meanwhile, early data from Germany and France suggest that it may take longer to administer the vaccine to the most vulnerable, and this may delay the reopening of the EU’s largest economies.

This chart is taken from Fathom’s Recovery Watch newsletter. Click here to subscribe to Recovery Watch.

Refresh this chart in your browser | Edit the chart in Datastream

Join a growing community of asset managers and stay up to date with the latest research from Refinitiv and partners to help you inform your investment decisions. Follow our Asset Management LinkedIn showcase page.

________________________________________________________________________________________

Refinitiv Datastream

Financial time series database which allows you to identify and examine trends, generate and test ideas and develop view points on the market.

Refinitiv offers the world’s most comprehensive historical database for numerical macroeconomic and cross-asset financial data which started in the 1950s and has grown into an indispensable resource for financial professionals. Find out more.

Article Topics Uncategorized
Article Keywords , ,

Get In Touch

Subscribe

We have updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.×